Senior Editor, Diagnostic Imaging
Emerging PET/CT Imaging Agent Shows Promise for Diagnosing Clear Cell Renal Cell Carcinoma
November 10th 2022Findings from a recent multinational phase III trial demonstrated that the investigational agent TLX250-CDx had an 86 percent sensitivity rate for detecting clear cell renal cell carcinoma via positron emission tomography/computed tomography (PET/CT).
Seven Takeaways from Lung-RADS 2022 for CT Lung Cancer Screening
November 10th 2022In the newly released Lung-RADS 2022 classification system for computed tomography (CT) lung cancer screening, the American College of Radiology (ACR) has noted a variety of updates including new classification criteria for atypical pulmonary cysts and airway nodules, time intervals for nodule growth and a new stepped management approach for Lung-RADS categories 3 and 4A.
New Computed Tomography System Offers Potential Benefits in Cardiac Imaging
November 9th 2022The recently launched Scenaria View Focus Edition computed tomography (CT) system features an advanced cardiac motion correction tool that reportedly provides significantly higher temporal resolution than conventional image reconstruction.
Current Insights on AI, Breast Cancer Screening and the FDA
November 8th 2022In a recently published article, researchers from Yale University discuss the pros and cons of current FDA regulations as they apply to the clearance and use of adjunctive artificial intelligence (AI) software with conventional breast cancer screening modalities such as mammography.
Study Shows Less Than 50 Percent Adherence to Follow-Up After Positive CT Findings for Lung Cancer
November 4th 2022In a multicenter study of 685 people who had positive findings for lung cancer on low-dose computed tomography (CT), researchers found that men, Black individuals, and smokers had lower rates of adherence with recommended follow-up care.
Is CT Overutilized in the ER for Suspected Urinary Stone Disease?
November 1st 2022Reviewing data from over 4 million patients who presented to emergency departments with suspected urinary stone disease between 2012 and 2018, researchers noted a greater than 10 percent decrease in visits with no imaging study and a greater than 10 percent increase in visits with CT imaging.
New Software Facilitates Use of Coronary CT Angiography Scans in Radiology Workflow
November 1st 2022Emphasizing ease of installation and a cloud-based service, Cleerly said its new Proxy software allows smooth transmission of coronary computed tomography angiography (CCTA) scans between interdisciplinary clinicians caring for patients with heart disease.
Deep Learning Improves CT Guidance for Revascularization of Coronary Total Occlusions
October 31st 2022Emerging research revealed that a deep learning model had a nearly twofold increase in successful segmentation and reconstruction of coronary total occlusions (CTOs) on coronary computed tomography angiogram (CCTA) and a 73 percent reduction in post-processing and measurement time in comparison to a conventional manual approach.
Radiotherapy for Prostate Cancer: Study Says MRI Guidance Significantly Reduces GU and GI Toxicities
October 28th 2022For patients undergoing stereotactic body radiotherapy (SBRT) for prostate cancer, the acute genitourinary (GU) toxicity rate associated with the procedure was 19 percent lower with magnetic resonance imaging (MRI) guidance in comparison to computed tomography (CT) guidance, according to new research presented recently at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Can AI-Powered Virtual Biopsies Improve Detection of Breast Lesion Subtypes on Digital Mammography?
October 27th 2022In separate test sets of Israeli women and United States women who had either ductal carcinoma in situ or invasive breast cancer, emerging artificial intelligence (AI) algorithms achieved an area under the curve (AOC) of 88 percent and 80 percent, respectively, for malignancy detection.
Transvaginal Ultrasound or MRI: Which is More Effective in Evaluating Endometrial Cancer?
October 26th 2022In a new study looking at pre-operative assessment of low-grade endometrial cancer, researchers found that while magnetic resonance imaging (MRI) had 20 percent higher specificity than transvaginal ultrasound for deep myometrial invasion, there was no difference in sensitivity.
Could an Emerging PSMA/PET Imaging Agent Improve the Detection of Recurrent Prostate Cancer?
October 25th 2022In a recent video interview from the American Society for Radiation Oncology (ASTRO) Annual Meeting, Benjamin Lowentritt, MD discussed the challenges of conventional imaging in diagnosing prostate cancer recurrence and the potential of an emerging high affinity, radiohybrid prostate-specific membrane antigen/positron emission tomography (PSMA/PET) imaging agent.
Study Suggests Shorter Duration of Radiation Therapy is Effective for High-Risk Prostate Cancer
October 24th 2022Five weeks of radiation therapy is just as effective as eight weeks of radiation treatment for men with high-risk prostate cancer, according to new research presented at the American Society for Radiation Oncology (ASTRO) Annual Meeting.
Philips Gets FDA Nod for MRI Head and Neck Radiotherapy Application
October 20th 2022For physicians performing radiotherapy treatment of soft tissue tumors in the head and neck, the MRCAT Head and Neck offers an artificial intelligence (AI) application that allows the use of magnetic resonance imaging (MRI) as the primary or sole imaging for procedure planning.
HeartFlow Garners FDA Clearances for Two AI-Powered Assessment Tools with CCTA
October 20th 2022Plaque Analysis and RoadMap Analysis, two artificial intelligence (AI)-enabled assessment products, may enhance clinical evaluation of coronary artery disease (CAD) on cardiac computed tomography angiography (CCTA).
GE Healthcare Launches Omni Legend PET/CT System at EANM Congress
October 17th 2022The inclusion of digital bismuth germanate (BGO) detector material with the Omni Legend system reportedly more than doubles the sensitivity of older PET/CT devices, improves scan times, and enhances the detection of small lesions.
Can Increased Post-Op Surveillance Chest CT Have an Impact for Colorectal Cancer Patients?
October 17th 2022Out of 1,600 patients who had surgery for colorectal cancer, nearly 15 percent had pulmonary metastases within 15.4 months and higher-risk patients experienced lung metastases within three months, according to new research presented at the Scientific Forum of the American College of Surgeons Clinical Congress.
Emerging Advances with PET/CT Imaging in Pediatric Radiology
October 14th 2022In a recent video interview, Andrew Trout, MD discussed key attributes and efficiencies in utilizing the Discovery MI Gen 2 digital positron emission tomography/computed tomography (PET/CT) system at the Cincinnati Children’s Hospital Medical Center.
GE Healthcare Announces Moves to Bolster Supply of Iodinated Contrast Media for CT and X-Ray Imaging
October 14th 2022A multi-year agreement with a large Chile-based supplier of raw iodine is part of GE Healthcare’s commitment to increase the production of iodinated contrast media, commonly used in computed tomography imaging, by 30 million annually in 2025.
Could a New PSMA-Derived Radiomics Model Help Detect Intraprostatic Lesions on PET/CT?
October 13th 2022An emerging radiomics model, derived from 68Ga-PSMA-11 PET, reportedly offers a superior area under the curve (AUC) and higher sensitivity than radiologist assessment in detecting intraprostatic lesions via positron emission tomography/computed tomography (PET/CT) in patients with prostate cancer.
Could Brain MRI Screening be Beneficial for Patients with Inflammatory Breast Cancer?
October 11th 2022While current consensus guidelines do not recommend the use of brain MRI screening in patients with breast cancer, a new study shows significantly elevated risks for the development of central nervous system metastasis in patients with inflammatory breast cancer.